Sweet Syndrome in a Patient with Chronic Hepatitis C

2014 ◽  
Vol 18 (6) ◽  
pp. 436-468 ◽  
Author(s):  
Danny Guo ◽  
Laurie M. Parsons
Keyword(s):  
Drug Reaction ◽  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Antiviral Agents ◽  
Skin Condition ◽  
Hepatitis C Infection ◽  
Sweet Syndrome

Background: Sweet syndrome (SS) is a rare skin condition that is classically idiopathic in etiology, but can also be triggered by malignancy, drug reaction, or infection. Both chronic hepatitis C infection and antiviral agents for the treatment of hepatitis C have been postulated to be possible triggers of SS. Objective: Herein, we present a case of SS in a patient with untreated chronic hepatitis C and cirrhosis but no other significant comorbidities.

scholarly journals Sustained Virologic Response for Chronic Hepatitis C Infection After 27 Days of Treatment with Sofosbuvir and Ribavirin

2014 ◽  
Vol 1 (1) ◽  
Author(s):  
Eric G. Meissner ◽  
Amy Nelson ◽  
Miriam Marti ◽  
Henry Masur ◽  
Anu Osinusi ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Sustained Virologic Response ◽  
Antiviral Agents ◽  
Virologic Response ◽  
Hepatitis C Infection ◽  
Direct Acting Antiviral ◽  
Direct Acting ◽  
Direct Acting Antiviral Agents

Abstract Successful treatment of chronic hepatitis C virus infection can now be achieved using direct-acting antiviral agents without interferon. In this report, we present a patient who achieved a sustained virologic response after 27 days of treatment with sofosbuvir and ribavirin. It is imperative to identify factors that allow for shorter treatment times in some individuals.

scholarly journals Extrahepaticus manifesztációk idült hepatitis C-vírus-fertőzöttekben

2017 ◽  
Vol 158 (16) ◽  
pp. 603-611
Author(s):  
Krisztina Hagymási ◽  
Anna Egresi ◽  
Gabriella Lengyel
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Antiviral Agents ◽  
Extrahepatic Manifestations ◽  
Hepatitis C Infection ◽  
Extrahepatic Manifestation ◽  
Direct Antiviral Agents

Abstract: The importance of chronic hepatitis C infection is significant. 3% of the World’s population is infected. There is at least one extrahepatic manifestation in 50% of HCV patients, which makes the prognosis and mortality worse. The pathomechanisms included are cryoglobulin production, immunmechanisms, and direct viral effects. The authors summarize the main extrahepatic manifestations, as well as treatment possibilities. The aim is to draw attention to this colourful infection in order to improve the recognition in the era of the new effective direct antiviral agents. Orv. Hetil., 2017, 158(16), 603–612.

Sign in / Sign up

Export Citation Format

Share Document